戻る Agenda
Radical Technologies: Changing the Future of Biopharmaceuticals
Session Chair(s)
Craig Lipset, MPH
Co-Chair
Decentralized Trials & Research Alliance | Buffalo Initiative, United States
In this DIAmond session, innovative thinkers project the impact of some of the most radical emerging technologies on the future of biomedical research. From real-time patient monitoring through mHealth technology to digitally enabled precision medicine to “research as a care option” supported by advanced analytics, the expert panel will explore radical changes that will improve the biopharmaceutical development process of the future and the radical technologies that will make them possible.
Learning Objective : Discuss the potential impact of one or more emerging new technologies on the development process and outcomes for biopharmaceutical products; Describe ways in which today's biopharmaceutical development process will be different in five years and what the impact will be for industry as well as the patient/consumer.
Speaker(s)
Panelist
Jeffry G. James, CPA, MBA
Wilmington Health and Innovo Research, United States
Chief Executive Officer
Panelist
Alicia Staley, MBA, MS
Medidata, a Dassault Systèmes Company, United States
Chief Patient Officer
Panelist
Julian M. Jenkins
Incyte Corporation, United States
Group Vice President, Development Operations and Project Management